Day Two - Afternoon - Global Alliance to Eliminate Lymphatic Filariasis
Day Two - Afternoon - Global Alliance to Eliminate Lymphatic Filariasis
Day Two - Afternoon - Global Alliance to Eliminate Lymphatic Filariasis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The achievements GPELF and<br />
GAELF<br />
• 8 million annual treatments <strong>to</strong> 500 million plus per year<br />
• $24 million in costs savings <strong>to</strong> 2008 alone<br />
• Low unit costs<br />
• Three pharmaceutical company donations<br />
• Recognition as a successful but different <strong>Alliance</strong><br />
• 52 country programmes-Regional templates and diversity of settings<br />
• <strong>Global</strong> programme with diverse disease epidemiology and health<br />
systems<br />
• Successful operational research-programme needs have focussed<br />
research<br />
• Platform for NTD integration concept-albendazole and ivermectin are<br />
not just an LF project but also an oncho and STH one combined-”three<br />
in one”<br />
• Most rapidly expanding public health programme in his<strong>to</strong>ry<br />
• Seamless linkage between GPELF and <strong>Alliance</strong>
Change language